CD40 ligation alters the cell cycle of differentiating keratinocytes

Journal of Investigative Dermatology

Volumn 114, Issue 3, 2000, Pages 581-586

  Grousson, Jérôme ^a   Ffrench, Martine ^b   Concha, Miguel ^c   Schmitt, Daniel ^a   Péguet Navarro, Josette ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

G1 phase; G2; M phase; S phase

Indexed keywords

CD40 ANTIGEN; CYCLIN A; CYCLIN E; GAMMA INTERFERON; REGULATOR PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; KERATINOCYTE; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034047604     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00905.x     Document Type: Article

References (44)

1. Albers KM, Taichman LB: Kinetics of withdrawal from the cell cycle in cultured human epidermal keratinocytes. J Invest Dermatol 82:161-164, 1984
2. 1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. Exp Cell Res 240:263-273, 1998
3. Bakken AH, Hamkalo BA. Techniques for visualization of genetic material. In: Hayat MA (ed.) Principles and Techniques of Electron Microscopy, Vol. 9. New York: Van Nostrand Reinhold Co., 1978, pp. 84-88
4. Banchereau J, Rousset F: Growing human B lymphocytes in the CD40 system. Nature 353:678-679, 1991
5. Benassi L, Ottani D, Fantini F, Marconi A, Chiodino C, Giannetti A, Pincelli C: 1,25-dihydroxyvitamin D-3, transforming growth factor beta 1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol 109:276-282, 1997
6. Bishop JY, Schattner EJ, Friedman SM: CD40 ligation impedes lymphoblastoid B cell proliferation and S-phase entry, Leuk Res 22:319-327, 1998
7. Björck P, Banchereau J, Flores-Romo L: CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 9:365-372, 1997
8. Caux C, Massacrier C, Vanbervliet B, Van Dubois B, Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272, 1994
9. Darzynkiewicz Z, Traganos F, Melamed MR: New cell cycle compartments identified by multiparamater flow cytometry. Cytometry 1:98-108, 1980
10. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota T, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808, 1992
11. Denfeld RW, Hollenbaugh D, Fehrenbach A, et al: CD40 is functionally expressed on human keratinocytes. Eur J Immunol 26:2329-2334, 1996
12. El-deiry WS, Tokino T, Velculescu VE, et al: Waf1 a potential mediator of p53 tumor supression. Cell 75:817-825, 1993
13. Eliopoulos AG, Dawson CW, Mosialos G, et al: CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13:2243-2254, 1996
14. Flatt PM, Price JO, Shaw A, Pietenpol JA: Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts. Cell Growth Differ 9:535-543, 1998
15. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP: CD40 expression by human fibroblasts. Clin Immunol Immunopathol 77:42-51, 1995
16. Funakoshi S, Longo DL, Beckwith M, et al: Inhibition of human B-cell lymphoma growth by CD40 ligation. Blood 83:2787-2794, 1994
17. Galibert L, Burdin N, De Saint-Vis B, Van Garrone P, Kooten C, Banchereau J, Rousset F: CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 183:77-85, 1996
18. Galy AHM, Spits H: CD40 is functionally expressed on thymic epithelial cells. J Immunol 149:775-782, 1982
19. Garrone P, Neidhardt E, Garcia E, Van Galibert L, Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265-1273, 1995
20. Gaspari AA, Sempowski GD, Chess P, Gish J, Phipps RP: Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 26:1371-1377, 1996
21. Grewal IS, Flavell RA: A central role of CD40 ligand in the regulation of CD4(+) T-cell responses. Immunol Today 17:410-414, 1996
22. Heath AW, Chang R, Harada N, et al: Antibodies to murine CD40 stimulated normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell Immunol 152:468-480, 1993
23. Hess S, Engelmann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 183:159-167, 1996
24. Hill A, Chapel N: X-linked immunodeficiency-the fruits of cooperation. Nature 361:494, 1993
25. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33-40, 1995
26. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925, 1995
27. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanisms of antigen-driven selection in germinal centers. Nature 342:929-931, 1989
28. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNFα, but strongly enhanced by interleukin-10. Eur J Immunol 25:1943-1950, 1995
29. Moran R, Darzynkiewicz Z, Staianco-Coico L, Melamed MR: Detection of 5-bromodeoxyuridine (BrdUrd) incorporation by monoclonal antibodies. J Histochem Cytochem 33:821-827, 1985
30. Nickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Antiproliferative effects of recombinant alpha-and gamma-interferons on cultured human keratinocytes. Lab Invest 51:697-701, 1984
31. Noelle RJ, Ledbetter JA, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus dependent B cell activation. Immunol Today 13:431-433, 1992
32. Péguet-Navarro J, Dalbiez-Gauthier C, Moulon C, et al: CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation, J Immunol 158:144-152, 1997
33. Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R: CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation. Cancer Res 56:1909-1916, 1996
34. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557-1565, 1995
35. 1 cyclins. Cell 73:1059-1065, 1995
36. Siegel J, Fritsche M, Mai S, Brandner G, Hess RD: Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfection. Oncogene 11:1363-1370, 1995
37. Spriggs MK, Armitage RJ, Strockbine L, et al: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543-1550, 1992
38. Valentine MA, Licciardi KA: Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur J Immunol 22:3141-3148, 1992
39. Van Essen D, Kikutani H, Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620-623, 1995
40. Van Kooten C, Banchereau J: CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv Immunol 6:1-77, 1996
41. Viac J, Schmitt D, Claudy A: CD40 expression in epidermal tumors. Anticancer Res 17:569-572, 1997
42. Wan J, Fogt F, Bistrian B, Istfan N: Evaluation of antitumor effect of tumor necrosis factor in terms of protein metabolism and cell cycle kinetics. Am J Physiol 265:C365-C374, 1993
43. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993
44. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L: Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol 58:209-216, 1995 cer/lymphoma/PUVA/skin cancer. J Invest Dermatol 114:5'87-590, 2000